# Progress Note 04 — Sick Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Theodore Roosevelt (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI012-SYN
- Date: 2026-08-03
- Fictional facility: St. Posthumous Health Center
- Fictional author: Amos Kettering, MD
- Calendar frame: modern shifted

- Visit type: Sick Visit
- Services: Problem-oriented office visit, established patient

## Chief complaint

Head cold for three days, now with wheeze and chest tightness. **S**

## History of present illness

Mr. Roosevelt is a 23-year-old man with moderate persistent asthma, well controlled since spring on budesonide-formoterol maintenance-and-reliever therapy (two inhalations twice daily plus as needed), who asked for a same-day visit. Three days ago he developed a runny nose and sore throat after a week of late sessions; a colleague had a cold. Since yesterday he has had wheeze, chest tightness, and a dry cough that woke him twice last night. He followed the yellow zone of his action plan: he has taken 8 reliever inhalations a day on top of his maintenance doses, which help for two to three hours. His home peak flow has been 400 to 440 L/min, against a personal best of 610. A home COVID-19 antigen test this morning was negative. He has not boxed or rowed for two days. He has had no fever above 37.8 °C, no chest pain, and no breathlessness at rest. **S**

| Element | Detail |
|---|---|
| Onset | Cold symptoms three days ago; wheeze since yesterday |
| Severity | Moderate: talks in sentences, peak flow about 70 percent of personal best, night waking twice |
| Reliever use | 8 inhalations a day of budesonide-formoterol in addition to maintenance, within the 12-a-day maximum |
| Action plan | Yellow zone followed correctly; called as the plan instructs when not back in the green zone within 48 hours |
| Context | Viral cold; colleague ill; long working days |
| Pertinent negatives | No fever above 37.8 °C, chest pain, sputum change, or breathlessness at rest; COVID-19 antigen test negative |
| Exacerbation history | One oral corticosteroid course from urgent care last winter, before controller therapy; no emergency visits or hospital stays |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tired; temperature up to 37.8 °C; no chills |
| Ears, nose, mouth, and throat | Positive | Clear rhinorrhea and sore throat; no ear or facial pain |
| Respiratory | Positive | Wheeze, chest tightness, and dry cough, worse at night; no hemoptysis |
| Cardiovascular | Negative | No chest pain or palpitations beyond a fast pulse after reliever doses |
| Gastrointestinal | Negative | No nausea, vomiting, or reflux symptoms |

5 systems reviewed. **S**

## Current medications

- Budesonide-formoterol 160/4.5 mcg inhaler, two inhalations twice daily for maintenance **S**
- Budesonide-formoterol 160/4.5 mcg inhaler, one inhalation as needed for symptoms and before exercise; no more than 12 inhalations a day in total **S**
- Prednisone 20 mg oral tablet, two tablets (40 mg) by mouth each morning for 5 days **S**

## Allergies

- No known allergy **S**

## Objective

BP 122/76 mmHg; pulse 98 bpm; respirations 20/min; temperature 37.6 °C; oxygen saturation 95% on room air; weight 72.2 kg; BMI 23.6 kg/m². All vital signs are synthetic.

Peak expiratory flow: 420 L/min (low). All results are synthetic.

## Physical examination

| System | Finding |
|---|---|
| General | Alert, talking in full sentences, sitting comfortably; not using accessory muscles |
| Ears, nose, and throat | Red, swollen nasal mucosa with clear discharge; pharynx mildly red without exudate |
| Respiratory | Respiratory rate 20; scattered expiratory wheeze in both lungs with a prolonged expiratory phase; no crackles or focal dullness; peak flow 420 L/min |
| Cardiovascular | Heart rate 98, regular; no murmur |
| Mouth | No oral thrush |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Moderate asthma exacerbation triggered by a viral cold** (J45.41). Peak flow 420 L/min, 69 percent of personal best, with oxygen saturation 95 percent and no features of a severe or life-threatening attack. Two days of increased reliever use have not brought him back to the green zone, so a short oral corticosteroid course is indicated. No signs of pneumonia, so a chest radiograph and antibiotics are not indicated. **S**
   - Prednisone 40 mg each morning for 5 days, with food; no taper needed for a short course.
   - Continue budesonide-formoterol two inhalations twice daily, and one inhalation as needed, up to 12 in total a day.
   - Inhaler technique checked with his own device and spacer: correct.
   - Rest from boxing and hard rowing until peak flow is back above 488 L/min.
   - Action plan updated: return or go to the emergency department for breathlessness at rest, peak flow below 305 L/min (50 percent), needing more than 12 inhalations a day, or poor relief.
2. **Moderate persistent asthma** (J45.40). Well controlled before this cold. This is his first exacerbation since starting controller therapy, and it raises his future exacerbation risk. **S**
   - Clinic review within one week of this exacerbation, by the CMID schedule.
   - Influenza vaccine as soon as this season's vaccine arrives.

## Medication changes

- Started: Prednisone 20 mg oral tablet, two tablets (40 mg) by mouth each morning for 5 days **S**

## Guideline basis

- Global Strategy for Asthma Management and Prevention, 2025 update (2025), Global Initiative for Asthma
- 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group (2020), National Heart, Lung, and Blood Institute (J Allergy Clin Immunol 2020;146(6):1217-1270)
- CMID: Clinical Monitoring Intelligence Database, asthma monograph (2026), Aether Forge

## Follow-up

- Nurse telephone check in three days. Clinic review within one week. Return the same day or go to the emergency department for red-zone symptoms. **S**
- Next scheduled visit 2026-09-14: six-month asthma review after a summer exacerbation. **S**
